These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 19204888)
21. A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic Oldenburg A; Briand N; Sørensen AL; Cahyani I; Shah A; Moskaug JØ; Collas P J Cell Biol; 2017 Sep; 216(9):2731-2743. PubMed ID: 28751304 [TBL] [Abstract][Full Text] [Related]
22. In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein. Rajendran V; Purohit R; Sethumadhavan R Amino Acids; 2012 Aug; 43(2):603-15. PubMed ID: 21989830 [TBL] [Abstract][Full Text] [Related]
23. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Araújo-Vilar D; Loidi L; Domínguez F; Cabezas-Cerrato J Horm Metab Res; 2003 Jan; 35(1):29-35. PubMed ID: 12669268 [TBL] [Abstract][Full Text] [Related]
24. Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD). Magracheva E; Kozlov S; Stewart CL; Wlodawer A; Zdanov A Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):665-70. PubMed ID: 19574635 [TBL] [Abstract][Full Text] [Related]
25. A Case of Familial Partial Lipodystrophy: From Clinical Phenotype to Genetics. Vouillarmet J; Laville M Can J Diabetes; 2016 Oct; 40(5):376-378. PubMed ID: 27026223 [TBL] [Abstract][Full Text] [Related]
26. High-throughput Second-generation Sequencing Technology Assisted Diagnosis of Familial Partial Lipodystrophy (Type 2 Kobberling-Dunnigan Syndrome): A Case Report. Deng M; Chen W; Qi Y Comb Chem High Throughput Screen; 2024; 27(2):346-351. PubMed ID: 37231758 [TBL] [Abstract][Full Text] [Related]
27. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N). Kutbay NO; Yurekli BS; Onay H; Altay CT; Atik T; Hekimsoy Z; Saygili F; Akinci B Eur J Intern Med; 2016 Apr; 29():37-9. PubMed ID: 26775134 [TBL] [Abstract][Full Text] [Related]
28. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy. Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308 [TBL] [Abstract][Full Text] [Related]
29. LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response. Chirico V; Ferraù V; Loddo I; Briuglia S; Amorini M; Salpietro V; Lacquaniti A; Salpietro C; Arrigo T Diabetes Metab; 2014 Jun; 40(3):224-8. PubMed ID: 24485160 [TBL] [Abstract][Full Text] [Related]
30. Familial partial lipodystrophy as differential diagnosis of polycystic ovary syndrome. Lewandowski KC; Lewiński A; Dąbrowska K; Jakubowski L; Gach A Endokrynol Pol; 2015; 66(6):550-4. PubMed ID: 26662654 [TBL] [Abstract][Full Text] [Related]
31. Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA. Thong KM; Xu Y; Cook J; Takou A; Wagner B; Kawar B; Ong AC Nephron Clin Pract; 2013; 124(1-2):31-7. PubMed ID: 24080738 [TBL] [Abstract][Full Text] [Related]
32. Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants. Patni N; Li X; Adams-Huet B; Vasandani C; Gomez-Diaz RA; Garg A J Clin Endocrinol Metab; 2019 Apr; 104(4):1099-1108. PubMed ID: 30418556 [TBL] [Abstract][Full Text] [Related]
33. [Biochemical, hormonal and genetic evaluation of the families of two Brazilian patients with type 2 familial partial lipodystrophy]. Caldas D; Silva Júnior WS; Simonetti JP; Costa EV; Farias ML Arq Bras Endocrinol Metabol; 2013 Nov; 57(8):583-93. PubMed ID: 24343626 [TBL] [Abstract][Full Text] [Related]
34. The novel loss of function Ile354Val mutation in PPARG causes familial partial lipodystrophy. Padova G; Prudente S; Vinciguerra F; Sudano D; Baratta R; Bellacchio E; Trischitta V; Vallone A; Sciacca L; Frittitta L Acta Diabetol; 2020 May; 57(5):589-596. PubMed ID: 31863320 [TBL] [Abstract][Full Text] [Related]
35. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism. Friesen M; Cowan CA Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996 [TBL] [Abstract][Full Text] [Related]
36. [A complex case of diabetes due to LMNA mutation]. Ambonville C; Bouldouyre MA; Laforêt P; Richard P; Benveniste O; Vigouroux C Rev Med Interne; 2017 Oct; 38(10):695-699. PubMed ID: 28545855 [TBL] [Abstract][Full Text] [Related]